First-in-Class Oncology Drug
A first-in-class oncology drug is the first approved medication to target a specific molecular pathway, receptor, protein, or cellular process involved in cancer development or progression. These drugs often represent major advances in cancer treatment and may establish a new standard of care.
Key Characteristics
Novel mechanism of action
Targets previously unaddressed biological pathways
Often developed using precision medicine approaches
Supported by extensive preclinical and clinical research
10 Views
hi